Reckitt vs Ross Stores
Side-by-side comparison of AI visibility scores, market position, and capabilities
British consumer health company with £14B revenue; Lysol, Mucinex, Nurofen, and Durex brands managing Mead Johnson infant formula litigation while competing with P&G and J&J.
About
Reckitt is a British multinational consumer health and hygiene company producing market-leading brands including Nurofen (ibuprofen), Strepsils, Dettol, Lysol, Durex, Mucinex, Enfamil infant formula, and Woolite — competing across OTC health, hygiene and home, and nutrition categories. Listed on the London Stock Exchange (LSE: RKT) and headquartered in Slough, England, Reckitt generates approximately £14 billion ($17 billion) in annual revenue. The company has undergone significant portfolio reshaping, divesting its Infant Formula & Child Nutrition (IFCN) business in some markets and selling Mead Johnson Nutrition operations.\n\nReckitt's business is organized into two segments: Health (Nurofen, Strepsils, Gaviscon, Mucinex, DayQuil/NyQuil in North America) and Hygiene and Home (Lysol/Dettol disinfectants, Finish dishwasher tablets, Vanish stain remover, Air Wick). The Health segment benefits from strong brand equity in OTC medications that command premium pricing. The Hygiene segment's Lysol brand benefited significantly from COVID-19 disinfectant demand and has sustained elevated brand awareness post-pandemic.\n\nIn 2025, Reckitt faces ongoing challenges from its $2.4 billion acquisition of Mead Johnson (Enfamil) — the company has faced significant litigation related to NEC (necrotizing enterocolitis) lawsuits claiming preterm infant formula contributed to infant deaths, resulting in large court judgments against Reckitt in 2024. The company is managing these legal liabilities while continuing to run its core consumer health and hygiene portfolio. Reckitt competes with Procter & Gamble, Johnson & Johnson, and Haleon for OTC health and hygiene market share. The 2025 strategy focuses on its Power Brands in health and hygiene, cost efficiency, and resolving the Mead Johnson litigation exposure.
Dublin CA largest US off-price retailer (NASDAQ: ROST) at $21.1B FY2024 sales (+3.7%), $2.1B net income; 2,273 stores expanding to 2,900 Ross + 700 dd's target competing with TJX Companies for off-price apparel shoppers.
About
Ross Stores, Inc. is a Dublin, California-based off-price variety retailer — publicly traded on NASDAQ (NASDAQ: ROST) as an S&P 500 Consumer Discretionary component — operating two retail banners: Ross Dress for Less (name-brand and designer apparel, footwear, and home fashion at 20-60% below department store prices) and dd's DISCOUNTS (20-70% below moderate department store prices for more budget-conscious shoppers) through approximately 107,000 employees. In fiscal year 2024, Ross Stores reported $21.1 billion in total sales (up 3.7% year-over-year), net earnings of $2.1 billion, and EPS of $6.32 (versus $5.56 in fiscal 2023), opening 89 new stores (75 Ross, 14 dd's) to end FY2024 with 2,205 total stores. As of 2025, Ross operates 2,273 stores across 44 states, Washington D.C., Guam, and Puerto Rico with long-term expansion targets of 2,900 Ross Dress for Less and 700 dd's DISCOUNTS locations. Founded in 1950 as a small department store chain in San Bruno, California, Ross transformed into an off-price retailer in 1982 under new management and grew into the largest US off-price retailer by revenue. The company sources merchandise through buying offices in New York City, Los Angeles, and Boston, accessing manufacturer overruns, retail liquidations, and closeout opportunities from thousands of vendors and brand partners. Seven distribution centers support the nationwide store network.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.